Literature DB >> 22434873

RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development.

Lai Peng1, Byunggil Yoo, Sumedha S Gunewardena, Hong Lu, Curtis D Klaassen, Xiao-Bo Zhong.   

Abstract

Cytochromes P450 (P450s) are a superfamily of enzymes that have critical functions in liver to catalyze the biotransformation of numerous drugs. However, the functions of most P450s are not mature at birth, which can markedly affect the metabolism of drugs in newborns. Therefore, characterization of the developmental profiles and regulatory mechanisms of P450 expression is needed for more rational drug therapy of pediatric patients. An animal model is indispensable for studying the mechanisms of postnatal development of the P450s. Hence we used RNA sequencing (RNA-Seq) to provide a "true quantification" of mRNA expression of all P450s in mouse liver during development. Liver samples of male C57BL/6 mice at 12 different ages from prenatal to adulthood were used. Total mRNAs of the 103 mouse P450s displayed two rapid increasing stages after birth, reflecting critical functional transition of liver during development. Four ontogenic expression patterns were identified among the 71 significantly expressed P450s, which categorized genes into neonatal-, adolescent-, adolescent/adult-, and adult-enriched groups. The 10 most highly expressed subfamilies of mouse P450s in livers of adult mice were CYP2E, -2C, -2D, -3A, -4A, -2F, -2A, -1A, -4F, and -2B, which showed diverse expression profiles during development. The expression patterns of multiple members within a P450 subfamily were often classified to different groups. RNA-Seq also enabled the quantification of known transcript variants of CYP2C44, CYP2C50, CYP2D22, CYP3A25, and CYP26B1 and identification of novel transcripts for CYP2B10, CYP2D26, and CYP3A13. In conclusion, this study reveals the mRNA abundance of all the P450s in mouse liver during development and provides a foundation for mechanistic studies in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434873      PMCID: PMC3362789          DOI: 10.1124/dmd.112.045088

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  32 in total

Review 1.  The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes.

Authors:  Ronald N Hines; D Gail McCarver
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

Review 2.  The untranslated regions of eukaryotic mRNAs: structure, function, evolution and bioinformatic tools for their analysis.

Authors:  G Pesole; G Grillo; A Larizza; S Liuni
Journal:  Brief Bioinform       Date:  2000-09       Impact factor: 11.622

Review 3.  Ontogeny of drug metabolizing enzymes in the neonate.

Authors:  Michael J Blake; Lisa Castro; J Steven Leeder; Gregory L Kearns
Journal:  Semin Fetal Neonatal Med       Date:  2005-01-25       Impact factor: 3.926

Review 4.  Xenobiotic-metabolizing cytochromes P450 in ontogeny: evolving perspective.

Authors:  Dharamainder Choudhary; Ingela Jansson; Mansoor Sarfarazi; John B Schenkman
Journal:  Drug Metab Rev       Date:  2004-10       Impact factor: 4.518

5.  Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms.

Authors:  R E Pearce; R R Gotschall; G L Kearns; J S Leeder
Journal:  Drug Metab Dispos       Date:  2001-12       Impact factor: 3.922

Review 6.  P450 genes: structure, evolution, and regulation.

Authors:  D W Nebert; F J Gonzalez
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 7.  The ethical boundaries of drug research in pediatrics.

Authors:  M Rowell; S Zlotkin
Journal:  Pediatr Clin North Am       Date:  1997-02       Impact factor: 3.278

8.  Developmental expression of the major human hepatic CYP3A enzymes.

Authors:  Jeffrey C Stevens; Ronald N Hines; Chungang Gu; Sevasti B Koukouritaki; Jason R Manro; Peter J Tandler; Matthew J Zaya
Journal:  J Pharmacol Exp Ther       Date:  2003-09-15       Impact factor: 4.030

Review 9.  The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans.

Authors:  P B Danielson
Journal:  Curr Drug Metab       Date:  2002-12       Impact factor: 3.731

10.  Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.

Authors:  J D Schuetz; D L Beach; P S Guzelian
Journal:  Pharmacogenetics       Date:  1994-02
View more
  39 in total

1.  Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing.

Authors:  Hong Lu; Julia Yue Cui; Sumedha Gunewardena; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Epigenetics       Date:  2012-07-09       Impact factor: 4.528

Review 2.  Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.

Authors:  Timothy S Tracy; Amarjit S Chaudhry; Bhagwat Prasad; Kenneth E Thummel; Erin G Schuetz; Xiao-Bo Zhong; Yun-Chen Tien; Hyunyoung Jeong; Xian Pan; Laura M Shireman; Jessica Tay-Sontheimer; Yvonne S Lin
Journal:  Drug Metab Dispos       Date:  2015-12-17       Impact factor: 3.922

3.  Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone.

Authors:  John T Szilagyi; Ludwik Gorczyca; Anita Brinker; Brian Buckley; Jeffrey D Laskin; Lauren M Aleksunes
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

4.  Consequences of Phenytoin Exposure on Hepatic Cytochrome P450 Expression during Postnatal Liver Maturation in Mice.

Authors:  Stephanie C Piekos; Liming Chen; Pengcheng Wang; Jian Shi; Sharon Yaqoob; Hao-Jie Zhu; Xiaochao Ma; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2018-06-08       Impact factor: 3.922

5.  Inhibition of the all-trans Retinoic Acid (atRA) Hydroxylases CYP26A1 and CYP26B1 Results in Dynamic, Tissue-Specific Changes in Endogenous atRA Signaling.

Authors:  Faith Stevison; Cathryn Hogarth; Sasmita Tripathy; Travis Kent; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2017-04-26       Impact factor: 3.922

6.  Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice.

Authors:  Felcy Pavithra Selwyn; Sunny Lihua Cheng; Theo K Bammler; Bhagwat Prasad; Marc Vrana; Curtis Klaassen; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2015-06-01       Impact factor: 4.849

7.  RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice.

Authors:  Hong Lu; Sumedha Gunewardena; Julia Y Cui; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-02-04       Impact factor: 3.922

8.  Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam.

Authors:  Wataru Ochiai; Hiroko Kobayashi; Satoshi Kitaoka; Mayumi Kashiwada; Yuya Koyama; Saho Nakaishi; Tomomi Nagai; Masaki Aburada; Kiyoshi Sugiyama
Journal:  J Nat Med       Date:  2018-03-17       Impact factor: 2.343

9.  Acetaminophen-Induced Liver Injury Alters Expression and Activities of Cytochrome P450 Enzymes in an Age-Dependent Manner in Mouse Liver.

Authors:  Yifan Bao; Pei Wang; Xueyan Shao; Junjie Zhu; Jingcheng Xiao; Jian Shi; Lirong Zhang; Hao-Jie Zhu; Xiaochao Ma; José E Manautou; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2020-02-24       Impact factor: 3.922

10.  Age-Specific Regulation of Drug-Processing Genes in Mouse Liver by Ligands of Xenobiotic-Sensing Transcription Factors.

Authors:  Cindy Yanfei Li; Helen J Renaud; Curtis D Klaassen; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2015-11-17       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.